Infinity Pharmaceuticals, Inc.
21 clinical trials · Sponsor
◉ Watch Infinity Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma (NCT03961698) | Infinity Pharmaceuticals, Inc. | 2019-12-17 |
| Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275) (NCT03980041) | Infinity Pharmaceuticals, Inc. | 2019-09-25 |
Track Infinity Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.